BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19914539)

  • 41. Molecular and clinicopathological markers of prognosis in breast cancer.
    Boyle DP; McCourt CM; Matchett KB; Salto-Tellez M
    Expert Rev Mol Diagn; 2013 Jun; 13(5):481-98. PubMed ID: 23782255
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gene expression profiling in breast cancer.
    Nasser SM
    J Med Liban; 2009; 57(2):83-8. PubMed ID: 19623883
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene expression-based diagnosis of efficacy of chemotherapy for breast cancer.
    Miki Y
    Breast Cancer; 2010 Apr; 17(2):97-102. PubMed ID: 20013078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Towards an individualization of systemic treatment of breast tumors].
    Bernard-Marty C; Cardoso F; Sotiriou C; Piccart MJ
    Bull Cancer; 2006 Aug; 93(8):791-7. PubMed ID: 16935784
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Advances in the Molecular Analysis of Breast Cancer: Pathway Toward Personalized Medicine.
    Rosa M
    Cancer Control; 2015 Apr; 22(2):211-9. PubMed ID: 26068767
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Genomics and clinical research for breast cancer].
    Bertucci F; Birnbaum D
    Med Sci (Paris); 2012 Mar; 28 Spec No 1():14-8. PubMed ID: 22494651
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene expression profiling of breast cancer to select women for adjuvant chemotherapy.
    Technol Eval Cent Assess Program Exec Summ; 2008 Apr; 22(13):1-8. PubMed ID: 18663816
    [No Abstract]   [Full Text] [Related]  

  • 48. The role of gene expression profiling in the management of breast cancer patients.
    Pines A
    Climacteric; 2012 Oct; 15(5):430-2. PubMed ID: 22480151
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular profiling: moving away from tumor philately.
    Reis-Filho JS; Weigelt B; Fumagalli D; Sotiriou C
    Sci Transl Med; 2010 Sep; 2(47):47ps43. PubMed ID: 20811040
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Personalized medicine: present and future of breast cancer management.
    Sabatier R; Gonçalves A; Bertucci F
    Crit Rev Oncol Hematol; 2014 Sep; 91(3):223-33. PubMed ID: 24725667
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tailoring Chemotherapy in Early-Stage Breast Cancer: Based on Tumor Biology or Tumor Burden?
    Ribnikar D; Cardoso F
    Am Soc Clin Oncol Educ Book; 2016; 35():e31-8. PubMed ID: 27249737
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular signatures predict outcomes of breast cancer.
    O'Shaughnessy JA
    N Engl J Med; 2006 Aug; 355(6):615-7. PubMed ID: 16899783
    [No Abstract]   [Full Text] [Related]  

  • 53. The role of molecular analysis in breast cancer.
    Geyer FC; Marchio C; Reis-Filho JS
    Pathology; 2009 Jan; 41(1):77-88. PubMed ID: 19089743
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression profiling to predict outcome in breast cancer: the influence of sample selection.
    Gruvberger SK; Ringnér M; Edén P; Borg A; Fernö M; Peterson C; Meltzer PS
    Breast Cancer Res; 2003; 5(1):23-6. PubMed ID: 12559041
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Breast cancer metastasis: when, where, how?
    Eccles SA; Paon L
    Lancet; 2005 Mar 19-25; 365(9464):1006-7. PubMed ID: 15781080
    [No Abstract]   [Full Text] [Related]  

  • 56. Will molecular classification replace traditional breast pathology?
    Schnitt SJ
    Int J Surg Pathol; 2010 Jun; 18(3 Suppl):162S-166S. PubMed ID: 20484283
    [No Abstract]   [Full Text] [Related]  

  • 57. Expression profiling predicts outcome in breast cancer.
    van 't Veer LJ; Dai H; van de Vijver MJ; He YD; Hart AA; Bernards R; Friend SH
    Breast Cancer Res; 2003; 5(1):57-8. PubMed ID: 12559048
    [No Abstract]   [Full Text] [Related]  

  • 58. Molecular classification of breast cancer: what the pathologist needs to know.
    Rakha EA; Green AR
    Pathology; 2017 Feb; 49(2):111-119. PubMed ID: 28040199
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and therapeutic perspectives of gene expression profiling for breast cancer.
    Chiuri VE; Leo G; Lorusso V
    Ann Oncol; 2007 Jun; 18 Suppl 6():vi58-62. PubMed ID: 17591834
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prediction of cancer outcome with microarrays.
    Goldhirsch A; Gelber RD; Viale G; Colleoni M; Coates AS
    Lancet; 2005 May 14-20; 365(9472):1685-6; author reply 1686. PubMed ID: 15894095
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.